Management of Tacrolimus-Telaprevir Drug-Drug Interaction in a Liver Transplant Patient With Hepatitis C Virus: Practical Considerations.

Transplantation

September 2015

1 Department of Clinical Pharmacology and Toxicology, CHU Nancy, Nancy, France. 2 Université de Lorraine, UMR 7365 CNRS-UL, IMoPA, Vandœuvre-lès-Nancy, France. 3 Pharmacovigilance Center of Lorraine, CHU Nancy, Nancy, France. 4 Department of Biochemistry, CHU Strasbourg, Strasbourg, France. 5 Department of Hepatology and Gastroenterology, CHU Nancy, Vandoeuvre-lès-Nancy, France.